Stocks
Natera, Inc.NTRA
NASDAQHealthcareDiagnostics & Research$187.85-1.29%
A developer of cell-free DNA–based genetic tests used in prenatal screening, oncology monitoring, and transplant rejection assessment. The company’s assays, including Panorama for noninvasive prenatal testing and Signatera for personalized cancer monitoring, are used by clinicians to detect genetic ...
Market Cap: $26.6B52W Range: $125.38 – $256.36
Congressional Interest in Natera, Inc. (NTRA)
4 members of Congress have disclosed 8 trades in Natera, Inc. (NTRA), a Healthcare company. The buy/sell breakdown shows 4 purchases versus 4 sales. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
8
Unique Politicians
4
Buys
4
Sells
4
Who in Congress Is Trading NTRA?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2025-09-22 | Josh Gottheimer | buy | $1K – $15K |
| 2025-08-22 | Josh Gottheimer | buy | $1K – $15K |